Diabetic cardiomyopathy: mechanisms, diagnosis and treatment

SA Hayat, B Patel, RS Khattar, RA Malik - Clinical science, 2004 - portlandpress.com
Independent of the severity of coronary artery disease, diabetic patients have an increased
risk of developing heart failure. This clinical entity has been considered to be a distinct …

Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy

B Parim, VV Sathibabu Uddandrao, G Saravanan - Heart Failure Reviews, 2019 - Springer
Diabetic complications are among the largely exigent health problems currently.
Cardiovascular complications, including diabetic cardiomyopathy (DCM), account for more …

EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology

B Hesse, K Tägil, A Cuocolo… - European journal of …, 2005 - Springer
The European procedural guidelines for radionuclide imaging of myocardial perfusion and
viability are presented in 13 sections covering patient information, radiopharmaceuticals …

Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients

C Ypenburg, MJ Schalij, GB Bleeker… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The response to cardiac resynchronization therapy (CRT) varies significantly among
individuals. Preliminary data suggest that the presence of myocardial viability may be …

Niacin: a re‐emerging pharmaceutical for the treatment of dyslipidaemia

H Vosper - British journal of pharmacology, 2009 - Wiley Online Library
Dyslipidaemias, particularly those characterized by the 'atherogenic profile'of high low‐
density lipoprotein‐cholesterol and triglycerides and low high‐density lipoprotein …

Effect of intramyocardial injection of autologous bone marrow–derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic …

SLMA Beeres, JJ Bax, P Dibbets… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Intramyocardial injection of bone marrow cells has been proposed as a new therapeutic
option for patients with chronic ischemic heart disease. We investigated whether autologous …

Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction

SLMA Beeres, JJ Bax, P Dibbets-Schneider… - The American journal of …, 2007 - Elsevier
The present study investigated the safety, feasibility, and potential efficacy of autologous
bone marrow cell injection in patients with chronic myocardial infarction and severe left …

Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA …

RHJA Slart, JJ Bax, DJ van Veldhuisen… - European journal of …, 2006 - Springer
Abstract Purpose 18 F-FDG PET is an important modality for myocardial viability assessment
in patients with left ventricular (LV) dysfunction. Dual-isotope simultaneous acquisition …

Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET

RHJA Slart, JJ Bax, DJ Veldhuisen, EE Wall… - Journal of nuclear …, 2006 - Springer
Background Traditionally, cardiac fluorodeoxyglucose (FDG) uptake is combined with
regional perfusion for optimal evaluation of viability. Gated FDG-positron emission tomogra …

Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability

SD Roes, TAM Kaandorp, N Ajmone Marsan… - European journal of …, 2009 - Springer
Purpose The purpose of this study was to compare contrast-enhanced MRI and nuclear
imaging with 99m Tc-tetrofosmin and 18 F-fluorodeoxyglucose (18 F-FDG) single photon …